Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-09-04), PCC Rokita's 5-Day RSI is 25.98.
The industry rank for PCC Rokita's 5-Day RSI or its related term are showing as below:
WAR:PCR's 5-Day RSI is ranked better than 88.47% of 1648
companies
in the Chemicals industry
Industry Median: 45.07
vs WAR:PCR: 25.98
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
PCC Rokita 5-Day RSI Related Terms
WAR:PCR vs DOW: 5-Day RSI Comparison
For the Chemicals subindustry, PCC Rokita's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PCC Rokita 5-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, PCC Rokita's 5-Day RSI distribution charts can be found below:
* The bar in red indicates where PCC Rokita's 5-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PCC Rokita (WAR:PCR) has a 5-Day RSI of 25.98 as of Sep. 04, 2026. According to the industry distribution chart, PCC Rokita ranks #190 out of 1648 companies in the Chemicals industry, placing it in the top 11.5%.
Is PCC Rokita's 5-Day RSI too high?
PCC Rokita's current 5-Day RSI is 25.98. The Chemicals industry median 5-Day RSI is 45.07. PCC Rokita's value of 25.98 is 42.4% below this industry median. Based on the distribution chart, PCC Rokita ranks #190 out of 1648 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, PCC Rokita has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PCC Rokita's 5-Day RSI compare to DOW?
According to the Chemicals industry distribution chart, PCC Rokita ranks #190 out of 1648 companies for 5-Day RSI. This places PCC Rokita in the top 12% of its industry — outperforming the majority of peers. The industry median 5-Day RSI is 45.07. PCC Rokita's value of 25.98 is 42.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Chemicals company?
The median 5-Day RSI among Chemicals companies is 45.07, based on 1,648 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PCC Rokita's current 5-Day RSI of 25.98 is 42.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median 5-Day RSI is 45.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PCC Rokita's current 5-Day RSI is 25.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCC Rokita stock overvalued right now?
Based on GuruFocus' analysis, PCC Rokita (WAR:PCR) is currently considered Fairly Valued. The stock's GF Value™ is zł68.57, compared to a current price of zł64.50 — trading 5.9% below its estimated fair value. The current 5-Day RSI is 25.98 and 42.4% below the Chemicals industry median of 45.07. PCC Rokita's overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For PCC Rokita (WAR:PCR), the current 5-Day RSI is 25.98 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PCC Rokita (WAR:PCR) Overvalued in 2026?
Based on GuruFocus' analysis, PCC Rokita stock appears to be undervalued.
The current stock price of zł64.50 is trading 5.9% below its estimated GF Value™ of zł68.57.
GuruFocus considers PCC Rokita to be Fairly Valued.
Key valuation signals for WAR:PCR:
5-Day RSI: 25.98
GF Value™: zł68.57 vs. price of zł64.50 (5.9% below fair value)
Industry Position: 42.4% below the Chemicals median (#190 of 1648)
No single metric tells the full story. See the WAR:PCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PCC Rokita SA is engaged in manufacturing chemicals. Its products include Polyols, Chloralkali, Chlorobenzene, Phosphorus derivatives, and Naphthalene derivatives. It serves adhesives, agrochemicals, building and construction, case, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and functional fluids, metallurgical, mining and drilling, oilfield, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, and water and wastewater treatment industries.
88GF Score
Get the complete analysis for WAR:PCR
5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PCR has been successfully added to your 
